Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/01/23 07:01:28 on US and Canada Markets.
Atlantica Reports Second Quarter 20 2 3 Financial Results Revenue for the first half of 2023 reached $554.6 million, a 1.4% increase year-over-year on a comparable basis 1 and a 0.1% decrease year-over-year. Adjusted EBITDA was $403.8 million for the first half...
Same-restaurant sales growth of 7.8% Income from operations margin of 5.3% and Restaurant level operating profit margin of 20.9% Net income of $8.0 million and Adjusted EBITDA of $25.8 million 9 system-wide restaurants opened across 6 states Raising 2023 Adjusted EBITDA gu...
CF Pacific Centre Celebrates Vancouver Pride with Special Patio Party on Saturday August 5 Canada NewsWire Free patio party includes drag performances and musical acts VANCOUVER, BC , Aug. 1, 2023 /CNW/ - In celebration of Vancouver Pride and the 2SLGBTQ+ communi...
EASTERSEALS DISABILITY ADVOCATES AND ALLIES AUTHOR NEW BIOGRAPHY SERIES FOR CHILDREN HIGHLIGHTING ROLE MODELS AND HISTORICAL FIGURES WITH DISABILITIES PR Newswire CHICAGO , Aug. 1, 2023 /PRNewswire/ -- Easterseals, a leading national nonprofit provider of service...
Vancouver, B.C, Aug. 01, 2023 (GLOBE NEWSWIRE) -- CryptoBlox Technologies Inc. (the “ Company ” or “ CryptoBlox ”) (CSE: BLOX), is pleased to announce the successful acquisition and implementation of a modular data centre (the “ Data Centre ” ...
-- Second quarter 2023 net revenue of $19.2 million from global sales of IMCIVREE ® (setmelanotide) -- -- Strong U.S. commercial progress continues with more than 125 new prescriptions for Bardet-Biedl syndrome (BBS) in 2Q 2023, more than 425 since FDA approval -- ...
R evolution Medicines Expect s to Conduct Late-Stage Development of RAS(ON) I nhibitor Drug C andidate Pipeline Supported by Fortified Balance Sheet Agreement is the Result of a Rigorous Process Conducted by Independe...
Encinitas, California--(Newsfile Corp. - August 1, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has appointed Carmine Stengone as an independent member to the Company's board of directors. Stengone currently serves as the President and CEO of Pipeline Therapeutics, a company developing prec...
– First participant is expected to be dosed in September 2023 with data anticipated in the second half of 2024 – – Cash runway extended through the end of 2025 – BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: T...
- Launched expansion to nearly double hydropower capacity to 350 MW - - Hosting Bitfarms Analyst Day on September 14 th in New York City - This news release constitutes a “designated news release” for purposes of the Company’s prospectus supplement dated...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
16.9%Change Percent:
Longeveron Inc. Company Name:
LGVN Stock Symbol:
NASDAQ Market:
longeveron.com Website: